SYNVISC Injection
Sold by melizza lifescience · Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India
Sold by melizza lifescience · Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India
DZ
AD
AI
AO
AR
+47 others
Importers · Distributors · Wholesalers
melizza lifescience is a Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup based in Rajkot Gujarat India.
Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India
Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.
DZ
AD
AI
AO
AR
+47 others
Product Name: SYNVISC® Injection Manufacturer: Sanofi Composition: Hylan G-F 20 (a high molecular weight derivative of hyaluronan)Therapeutic Category: Orthopedic / Osteoarthritis TreatmentProduct Description: SYNVISC® is a viscosupplement used for the treatment of knee pain associated with osteoarthritis (OA) in patients who have not responded adequately to conservative treatments (e.g., physiotherapy, painkillers). It is an injectable solution containing Hylan G-F 20, which mimics the natural hyaluronic acid found in synovial fluid. This helps restore lubrication and cushioning in the joints, thereby reducing pain and improving mobility. Indications: Painful osteoarthritis of the knee Alternative to oral analgesics or NSAIDs in patients with high risk of side effects Helps delay the need for surgical intervention in some cases Mechanism of Action: Replenishes the viscoelastic properties of synovial fluid Enhances joint lubrication and shock absorption Reduces joint pain and stiffness Improves physical function and mobility
Dosage & Administration:
Packaging: Prefilled syringe: 2 mL or 6 mL (depending on regimen)
Storage:
Important Notes:
Description provided by melizza lifescience.
| Manufacturer | Sanofi |
|---|---|
| Therapeutic Category | Orthopedic / Osteoarthritis Treatment |
| Composition | Hylan G-F 20, a high molecular weight hyaluronan derivative |
| Dosage Forms | Prefilled injectable syringes |
| Volume per Syringe | 2 mL or 6 mL |
| Intended Use | Treatment of knee OA pain and improving joint mobility |
| Recommended Dosage | One injection per week for 3 weeks or single injection of 6 mL |
| Contraindications | Infection or inflammation in target joint |
| Storage | Room temperature below 25°C, protect from light, do not freeze |
| Category | Healthcare > Orthopedic Products > Osteoarthritis Treatments > Viscosupplements |
|---|---|
| Primary application | Wholesale, distribution, and international sourcing |
| Brand | Not specified |
| Product type | Product |
| Lead time | On request |
|---|---|
| Packaging | As per buyer requirement |
| Storage condition | As recommended by supplier |
| Origin | India |
| Form | As listed by supplier |
| Minimum order | 1 Piece |
|---|---|
| Lead time | On request |
| Payment terms | As per negotiated commercial agreement. |
| Checkout type | enquiry |
Common questions B2B buyers ask before sourcing SYNVISC Injection. Answers compiled from verified sellers' commercial terms and platform data.
Verified
Verified
Verified
Verified
Verified
Verified
Verified
Verified
Post one RFQ and get quotes from all verified sellers within 48 hours. No commitment, no spam.
Post a RFQ